1. Home
  2. THRM vs MNMD Comparison

THRM vs MNMD Comparison

Compare THRM & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$38.75

Market Cap

1.1B

ML Signal

HOLD

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$13.84

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
MNMD
Founded
1991
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
THRM
MNMD
Price
$38.75
$13.84
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$39.00
$30.33
AVG Volume (30 Days)
169.4K
2.1M
Earning Date
02-18-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$1,468,728,000.00
N/A
Revenue This Year
$3.56
N/A
Revenue Next Year
$2.52
N/A
P/E Ratio
$39.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.75
$4.70
52 Week High
$41.09
$15.29

Technical Indicators

Market Signals
Indicator
THRM
MNMD
Relative Strength Index (RSI) 58.14 60.38
Support Level $35.86 $13.06
Resistance Level $37.57 $15.29
Average True Range (ATR) 0.97 0.84
MACD 0.11 0.10
Stochastic Oscillator 71.55 60.49

Price Performance

Historical Comparison
THRM
MNMD

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: